HOXD13 and neoplasm: Furthermore, we demonstrated that sPD-1-CAR-NK cells exhibited more potential antitumor efficacy than HER2-CAR-NK cells plus sPD-1, because there was more sPD-1 in the tumor tissue in the mice treated with sPD-1-CAR-NK cells (Figure 5E).